Keywords: Advinus, Tata, Pharma R&D, Foray into formulations

India’s Tata Group pharma R&D unit Advinus to double drug discovery projects

Article | 16 September 2010

Print This

India-based Advinus Therapeutics, the pharma R&D wing of the Tata Group, has earmarked investment ranging between 20 billion rupees ($430 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in